Kamada (KMDA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $467.05M
Last updated: Nov 17, 2026 at 11:04 AM ET
Kamada (KMDA) Financials: Revenue, Profit and Cash Flow
Kamada reported revenue of $180.46M for the fiscal year ended Dec 31, 2025, up 12.1% from the year before. That year, net income was $20.20M with a net margin of 11.2%, operating cash flow was $27.59M and free cash flow was $16.93M. The quarter ended Sep 30, 2026 had revenue of $51.07M and net income of $7.84M.
Revenue and Margins
The operating margin was 14.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $77.49M, a compound annual rate of 9.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $180.46M | +12.1% | 42.3% | 14.5% | 11.2% |
| Dec 2024 | $160.95M | +12.9% | 43.5% | 12.5% | 9.0% |
| Dec 2023 | $142.52M | +10.2% | 38.9% | 7.1% | 5.8% |
| Dec 2022 | $129.34M | +24.8% | 36.1% | 3.5% | -1.8% |
| Dec 2021 | $103.64M | -22.2% | 29.3% | -0.7% | -2.2% |
| Dec 2020 | $133.25M | +4.8% | 35.7% | 14.4% | 12.9% |
| Dec 2019 | $127.19M | +11.1% | 39.1% | 17.9% | 17.5% |
| Dec 2018 | $114.47M | +11.3% | 36.2% | 16.8% | 19.5% |
| Dec 2017 | $102.83M | +32.7% | 31.2% | 7.2% | 6.7% |
| Dec 2016 | $77.49M | N/A | 27.9% | -7.5% | -8.7% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 39.7% from the year before. In the quarter ended Sep 2026, net income rose 47.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $180.46M | $160.95M | $142.52M | $129.34M | $103.64M | $133.25M | $127.19M | $114.47M | $102.83M | $77.49M |
| Cost of revenue | $104.05M | $90.99M | $87.03M | $82.64M | $73.31M | $85.69M | $77.45M | $73.00M | $70.74M | $55.84M |
| Gross profit | $76.41M | $69.97M | $55.49M | $46.70M | $30.33M | $47.55M | $49.74M | $41.47M | $32.09M | $21.65M |
| Research and development | $12.99M | $15.19M | $13.93M | $13.17M | $11.36M | $13.61M | $13.06M | $9.75M | $11.97M | $16.25M |
| Operating income | $26.23M | $20.05M | $10.06M | $4.53M | -$696.00K | $19.24M | $22.78M | $19.26M | $7.44M | -$5.84M |
| Net income | $20.20M | $14.46M | $8.28M | -$2.32M | -$2.23M | $17.14M | $22.25M | $22.30M | $6.90M | -$6.73M |
| EBITDA | $39.25M | $27.80M | $22.44M | $10.81M | $4.01M | $25.07M | $27.79M | $23.60M | $11.12M | -$1.38M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51.07M | $54.92M | $45.24M | $44.68M | $47.01M | $44.75M | $44.02M | $39.01M | $41.74M | $42.47M | $37.74M | $36.43M |
| Gross profit | $22.90M | $22.47M | $19.12M | $16.97M | $19.76M | $18.93M | $20.75M | $17.03M | $17.23M | $18.95M | $16.75M | $14.41M |
| Operating income | $10.20M | $9.51M | $6.95M | $3.55M | $7.82M | $7.07M | $7.79M | $5.08M | $5.29M | $5.64M | $4.04M | $2.78M |
| Net income | $7.84M | $9.26M | $4.13M | $3.56M | $5.30M | $7.38M | $3.96M | $3.81M | $3.86M | $4.43M | $2.37M | $5.06M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $2.12M by $73.36M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $378.79M | $372.25M | $354.91M | $322.38M | $318.67M | $210.66M | $173.80M | $138.12M | $122.11M | $99.70M |
| Current assets | $193.12M | $184.35M | $169.96M | $139.00M | $130.04M | $177.91M | $143.56M | $110.89M | $96.88M | $77.08M |
| Cash and equivalents | $75.48M | $78.44M | $55.64M | $34.26M | $18.59M | $70.20M | $42.66M | $18.09M | $12.68M | $9.97M |
| Total liabilities | $109.66M | $112.79M | $110.89M | $146.36M | $141.84M | $32.03M | $38.48M | $25.74M | $32.62M | $32.95M |
| Short-term debt | $2.12M | $1.63M | $1.38M | $5.46M | $3.79M | $1.31M | $1.51M | $562.00K | $614.00K | $412.00K |
| Long-term debt | N/A | N/A | N/A | $12.96M | $17.41M | $36.00K | $257.00K | $716.00K | $1.37M | $1.36M |
| Shareholder equity | $269.13M | $259.46M | $244.02M | $176.02M | $176.82M | $178.64M | $135.32M | $112.38M | $89.49M | $66.74M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $382.48M | $383.16M | $383.02M | $378.79M | $377.21M | $368.17M | $375.11M | $372.25M | $351.21M | $351.04M | $343.17M | $354.91M |
| Total liabilities | $114.28M | $113.60M | $123.63M | $109.66M | $111.98M | $108.22M | $123.15M | $112.79M | $95.94M | $99.89M | $96.66M | $110.89M |
| Cash and equivalents | $75.27M | $29.47M | $32.92M | $75.48M | $72.00M | $65.98M | $76.25M | $78.44M | $72.00M | $56.55M | $48.19M | $55.64M |
| Shareholder equity | $268.20M | $269.56M | $259.39M | $269.13M | $265.23M | $259.95M | $251.96M | $259.46M | $255.27M | $251.15M | $246.51M | $244.02M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 61.4% of operating cash flow. Dividends came to 73.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $27.59M | $47.59M | $4.32M | $28.59M | -$9.17M | $19.11M | $28.44M | $10.55M | $3.89M | $1.90M |
| Capital expenditures | $10.66M | $10.74M | $5.85M | $3.78M | $3.88M | $5.49M | $2.37M | $2.88M | $4.45M | $2.64M |
| Free cash flow | $16.93M | $36.85M | -$1.53M | $24.80M | -$13.04M | $13.62M | $26.07M | $7.66M | -$559.00K | -$744.00K |
| Dividends paid | $12.49M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$10.65M | -$10.74M | -$5.84M | -$3.78M | -$63.46M | -$13.13M | -$581.80K | -$5.18M | -$15.89M | $1.64M |
| Financing cash flow | -$19.86M | -$13.91M | $22.68M | -$9.34M | $19.33M | $23.36M | -$1.58M | -$587.00K | $15.32M | $1.49M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.53M | $18.07M | -$291.00K | $7.82M | $10.42M | $8.02M | -$513.00K | $10.40M | $22.21M | $13.96M | $1.02M | $4.41M |
| Capital expenditures | $3.50M | $2.11M | $973.00K | $2.86M | $3.59M | $2.01M | $1.47M | $2.92M | $2.12M | $3.01M | $2.68M | $1.97M |
| Free cash flow | $16.04M | $15.96M | -$1.26M | $4.96M | $6.83M | $6.01M | -$1.98M | $7.47M | $20.09M | $10.95M | -$1.66M | $2.44M |
Frequently Asked Questions About KMDA
What is Kamada's annual revenue?
Kamada reported revenue of $180.46M for the fiscal year ended Dec 31, 2025.
How fast is Kamada's revenue growing?
Revenue was up 12.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.7%.
Is Kamada profitable?
Yes. Kamada reported net income of $20.20M for the fiscal year ended Dec 31, 2025, with a net margin of 11.2%.
How much free cash flow does KMDA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $27.59M minus capital expenditures of $10.66M produced free cash flow of $16.93M.
How much debt does Kamada have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $2.12M and cash and equivalents of $75.48M.
KMDA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors